Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination
DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): StudyVivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022 (news with additional features)31.07.2022 / 18:05 The issuer is solely responsible for the content of t...
United States San Diego Cynthia Lemere Manuela Bader Michael Schaeffer Alzheimer Association International Conference
Source: pharmiweb.com